Developing Next-generation Cancer Treatments
Therapeutic Portfolio
.webp)
Prostate Cancer
.webp)
Melanoma
.webp)
Pancreatic and Breast Cancer
Delivering an Unmatched
Supply of Alpha Isotopes
ALPHA 212
Alpha 212 is the isotope Lead-212 or ²¹²Pb and powers AdvanCell's therapeutic pipeline.
AdvanCell routinely manufactures Alpha 212 through a fleet of ²¹²Pb Generators enabling full control of the supply chain for the global manufacture of targeted alpha therapies.
.webp)